SEC Form 4 · accession 0001562180-16-003351
Dermira, Inc. · DERM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas G Wiggans
Officer — CEO & Chairman of the Board · Director
Period of report
Nov 1, 2016
Accepted (ET)
Nov 2, 2016 · 4:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001557883
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Nov 1, 2016 | S | 11,000 | $31.19 | D | 145,180 | I | By the Wiggans Living Trust dated 5/14/02 |
| Common StockF4 | holding | — | — | — | 5,384 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These trades were made pursuant to a Rule 10b5-1 trading plan.
- F2This transaction was executed in multiple trades at prices ranging from $30.79 to $31.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3The Reporting Person is a Co-Trustee.
- F4These shares include prior ESPP purchases.